What did you miss at ACOG?
From COVID-19 to climate change to vulvovaginal candidiasis, the annual meeting offered something for everyone.
For the first time in 3 years, experts from the United States and beyond reunited in person for the American College of Obstetricians and Gynecologists’ Annual Clinical & Scientific Meeting held in May in San Diego, California. Clinicians received updates on the latest research, newest technologies, and best clinical recommendations in obstetrics and gynecology.
This year’s theme was “Reconnect, recharge, and reset,” and every facet of the meeting reflected that. Attendees engaged in meaningful discussions, rediscovered their passions, and identified the pulse of the industry—from adapting to the climate crisis and changes in abortion care legislation to embracing artificial intelligence in their daily practice.
Contemporary OB/GYN®’s editorial team was onsite covering an array of topics such as social media misinformation, digital apps in obstetric care, contraception, and osteoporosis management guidelines.
Some sessions of note include:
How climate change is making your patients sick, and what you can do about it
Asthma. Allergies. Eczema. Type 2 diabetes. Nathaniel DeNicola, MD, MSHP; Emily Sbiroli, MD; Vi Nguyen, MD, FAAP; and Colin Nackerman, MD, spoke about disease states caused or exacerbated by climate change, and what clinicians can do to mitigate
this crisis.
Understanding the impact COVID-19 vaccines have on fertility and pregnancy
There have been many unknowns surrounding COVID-19 vaccination and adverse effects, but to women in their childbearing years, the possible impact on their fertility and fetal health may carry the most weight. Three experts sought to outline exactly how vaccination against COVID-19 could affect reproductive health, fertility, and infant outcomes.
Recharging women’s sexual health: Taking back female sexual function
Lyndsey Harper, MD, FACOG, IF; and Laurie Mintz, PhD, explained how obstetrician-gynecologists can help women take charge of their sexual function and how to address internalized shame, medical contributors to sexual dysfunction, and treatment plans for your patients.
Making obstetrics and gynecology a more diverse and equitable environment
Metrics, wellness models, and management change are essential to advancing diversity, equity, and inclusion in obstetrics and gynecology, according to an EdTalk presented by Lisa Foglia, MD, FACOG; Andrea L. Braden, MD, FACOG; and Catherine Cansino, MD, MPH.
Looking at the first FDA-approved medication for RVVC
Jack Sobel, MD, discussed how recurrent vulvovaginal candidiasis (RVVC), a chronic version of vulvovaginal candidiasis, affects women. He also delved into past treatments and the newly FDA-approved drug oteseconazole (Vivjoa; Mycovia).
Multiple posters and abstracts also displayed study data on a variety of topics including postpartum depression and intrauterine device use, as well as experiences with use of medication abortion before and during the COVID-19 pandemic.
